Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option in Cervicogenic Headache
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study will highlight and validate chiropractic spinal manipulative therapy (CSMT) for cervicogenic headache (CEH). If the method proves to be effective, it will provide a new non-pharmacological treatment option for CEH. This is especially important since pharmacological management has minor effect in CEH, and alternative treatment options are warranted. The applied methodology of the study will aim towards the highest possible research standards. This international study is a collaboration between Akershus University Hospital, Innlandet Hospital and University of Oslo (UiO), Norway and Macquarie University, Australia. The multidisciplinary professional backgrounds are physiotherapy, chiropractic and medicine. By increasing the methodological quality of the investigators research to a very high level, the investigators see the method to work as a guide to increase the quality of chiropractic research in the future, as previous randomized clinical trials (RCTs) of CEH used methodology showing room for improvement.
Study hypothesis:
CSMT using the Gonstead method reduces days with CEH by at least 25% as compared to placebo (sham manipulation, i.e. broad non-specific contact, non-directional, low velocity and low amplitude) and no intervention (control group).
| Condition | Intervention | Phase |
|---|---|---|
|
Cervicogenic Headache |
Other: Chiropractic Other: Sham Chiropractic |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option in Cervicogenic Headache? A Randomized Controlled Clinical Trial. |
- Number of headache days [ Time Frame: Change from baseline to post-treatment, 3, 6, 12 months follow-up ] [ Designated as safety issue: No ]
- 25% reduction in number of headache days between active treatment and sham.
- 25% reduction in number of headache days between active treatment and control group.
- Headache duration [ Time Frame: Change from baseline to post-treatment, 3, 6, 12 months follow-up ] [ Designated as safety issue: No ]
- 25% reduction in headache duration in hours between active treatment and sham.
- 25% reduction in headache duration in hours between active treatment and control group.
- Self reported VAS [ Time Frame: Change from baseline to post-treatment, 3, 6, 12 months follow-up ] [ Designated as safety issue: No ]
- 25% self-reported improvement on VAS between active treatment and sham.
- 25% self-reported improvement on VAS between active treatment and control group.
- Headache index [ Time Frame: Change from baseline to post-treatment, 3, 6, 12 months follow-up ] [ Designated as safety issue: No ]
- 25% reduction in headache index (frequency x duration x intensity) between active treatment and sham.
- 25% reduction in headache index between active treatment and control group.
- Headache medication [ Time Frame: Change from baseline to post-treatment, 3, 6, 12 months follow-up ] [ Designated as safety issue: No ]
- 50% reduction in headache medication between active treatment and sham.
- 50% reduction in headache medication between active treatment and control group.
- Sub-analysis on x-ray findings [ Time Frame: Change formbaseline to post-treatment, 3, 6, 12 months follow-up ] [ Designated as safety issue: No ]Sub-analysis will be done on participants with structural deformities vs. normal x-ray findings.
| Estimated Enrollment: | 48 |
| Study Start Date: | September 2012 |
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Sham Comparator: Sham Chiropractic
Sham Chiropractic manipulative therapy.
|
Other: Sham Chiropractic |
|
No Intervention: Control group
No intervention: Control group.
|
|
|
Active Comparator: Chiropractic Spinal Manipulative Therapy
Active intervention: Chiropractic Spinal Manipulative Therapy
|
Other: Chiropractic
Chiropractic Spinal Manipulative Therapy
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- CEH according to at least three major criteria of the CHISG not including occipital nerve blockage
- Age 18-70 years
Exclusion Criteria:
- Contraindication to spinal manipulation
- Chiropractic treatment within the last 12 months
- Radiculopathy
- Depression
- Pregnancy
- Participants whom become pregnant during the migraine trial will also be excluded from analysis from the time of pregnancy
- Participants who change their prophylactic medical regime for headaches will be excluded in the analysis from the time of change
Contacts and Locations| Norway | |
| Research Centre, Akershus University Hospital | Recruiting |
| Lørenskog, Norway, 1478 | |
| Contact: Michael B Russell, Professor + 47 67 96 83 81 m.b.russell@medisin.uio.no | |
| Contact: Karin A Vassbakk, dep. manager +47 480 92 669 Karin.Anne.Vassbakk@ahus.no | |
| Principal Investigator: Aleksander Chaibi, PhD student | |
| Study Director: | Michael B Russell, Professor | Head and Neck research Group, Research Centre, Akershus University Hospital |
More Information
Publications:
| Responsible Party: | Aleksander Chaibi, PhD student, Akershus University College |
| ClinicalTrials.gov Identifier: | NCT01687881 History of Changes |
| Other Study ID Numbers: | CEH-K34KSF-AHUS, 2829002 |
| Study First Received: | September 11, 2012 |
| Last Updated: | September 15, 2012 |
| Health Authority: | Norway: Ethics Committee Norway: Norwegian Social Science Data Services |
Keywords provided by University Hospital, Akershus:
|
Chiropractic Manipulative therapy Cervicogenic headache |
Additional relevant MeSH terms:
|
Headache Post-Traumatic Headache Pain Neurologic Manifestations Nervous System Diseases |
Signs and Symptoms Headache Disorders, Secondary Headache Disorders Brain Diseases Central Nervous System Diseases |
ClinicalTrials.gov processed this record on June 17, 2013